{
    "doi": "https://doi.org/10.1182/blood.V128.22.4465.4465",
    "article_title": "Discovery and Preclinical Development of Novel CD74-Targeting Antibody-Drug Conjugates (ADCs) with Significant Activity in Multiple Myeloma (MM) Cell Lines and Xenograft Models ",
    "article_date": "December 2, 2016",
    "session_type": "652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster III",
    "abstract_text": "CD74, also known as HLA-DR-associated invariant chain, is a type II transmembrane glycoprotein highly expressed in many B-cell malignancies. The limited expression of CD74 in normal tissues suggests it may be a suitable ADC target for these tumor types. Accordingly, we engineered an anti-CD74 human IgG1 antibody (SP7219) using novel Fab-based ribosome display methods. The selected Fabs were readily reformatted and directly screened as IgGs using Sutro's unique high-throughput, cell-free protein synthesis platform, Xpress CF TM . We then developed novel, potent ADCs, SP7676 and SP7675 (STRO-001), comprised of our lead antibody (SP7219) conjugated to non-cleavable DBCO-maytansinoid linker-warheads with an average drug-antibody ratios (DAR) of 2. We used site-specific conjugation technology which results in a high degree of homogeneity characterized by the drug linker covalently binding to a single defined site. The sites for conjugation were selected based on highest cell killing activity and stablity in vitro and in vivo . Both ADCs demonstrate potent cell killing activity across multiple B-cell tumor lines in vitro , and anti-tumor activity in preclinical multiple myeloma xenograft models. In vitro cytotoxicity assays show nanomolar potency of STRO-001 in four MM cell lines: Mc/CAR (IC 50 0.8 nM), MM.1S (IC 50 10-11 nM), U266B1 (IC 50 8.5 -9.3 nM), and ARP-1 (IC 50 4.3-22 nM). CD74 cell surface expression is required for ADC anti-proliferative effect but the expression level does not seem to correlate with in vitro potency. SP7676 elicited a robust anti-tumor response in the ANBL-6 multiple myeloma xenograft model. Durable regressions were observed in all mice at \u2265 3 mg/kg, with equivalent efficacy (regression) at 3 mg/kg (every 3 days x5) and 10 mg/kg (every 3 days x5 or weekly x3). SP7676 also elicited a clear survival benefit in a disseminated multiple myeloma CAG xenograft model starting at 1mg/kg every 3 days x 5 doses. Similarly, both SP7676 and STRO-001 inhibited the formation of internal visceral tumors in the ARP-1 xenograft model after 3 weekly doses of 3 mg/kg. Evaluation of our lead candidate, STRO-001 in additional MM cell lines and primary patient samples is planned. The tolerability of STRO-001 in non-human primates is under evaluation. STRO-001 was administered to cynomolgous monkeys in an exploratory dose-escalating study up to 30 mg/kg x 2 doses on Day 1 and 15. STRO-001 reduces normal B-cell populations at \u22651 mg/kg after a single dose, providing pharmacodynamic evidence of B-cell targeting while other hematopoietic lineages are mostly affected only at the highest dose studied. Anticipated hematologic toxicities were readily reversible at 1, 3 and 10 mg/kg and target organs of interest were identified. Based on these encouraging data, STRO-001 is advancing to IND-enabling studies for the treatment of CD74 expressing multiple myeloma and other B-cell malignancies. Disclosures Abrahams: Sutro Biopharma: Employment. Li: Sutro Biopharma: Employment. Yu: Sutro Biopharma: Employment. Krimm: Sutro Biopharma: Employment. Kahana: Celgene: Employment. Narla: Celgene: Employment. Schwartz: Celgene: Employment. Boylan: Celgene: Employment. Hoffmann: Sutro Biopharma: Employment. Steiner: Sutro Biopharma: Employment. Zawada: Sutro Biopharma: Employment. Stephenson: Sutro Biopharma: Employment. Bruhns: Sutro Biopharma: Employment. DeAlmeida: Sutro Biopharma: Employment. Matheny: Sutro Biopharma: Employment. Bussell: Sutro Biopharma: Employment. Galan: Sutro Biopharma: Employment. Kline: Sutro Biopharma: Employment. Vasquez: Sutro Biopharma: Employment. Yam: Sutro Biopharma: Employment. Stafford: Sutro Biopharma: Employment. Heinsohn: Sutro Biopharma: Employment. Sato: Sutro Biopharma: Employment. Molina: Sutro Biopharma: Employment. Hallam: Sutro Biopharma: Employment. Lupher: Sutro Biopharma: Employment.",
    "topics": [
        "antibodies",
        "cell lines",
        "multiple myeloma",
        "transplantation, heterologous",
        "neoplasms",
        "mechlorethamine",
        "cancer",
        "cystic fibrosis",
        "cytotoxicity",
        "glycoprotein"
    ],
    "author_names": [
        "Cristina Abrahams, PhD",
        "Xiaofan Li, PhD",
        "Abigail Yu, PhD",
        "Stellanie Krimm",
        "Jason Kahana, PhD",
        "Rama Krishna Narla, PhD",
        "Eric Schwartz, PhD",
        "John Boylan, PhD",
        "Heidi Hoffmann, PhD",
        "Alexander Steiner, M.S.",
        "James Zawada, PhD",
        "Heather Stephenson",
        "Maureen Bruhns, PhD",
        "Venita DeAlmeida, PhD",
        "Shannon Matheny, PhD",
        "Stuart Bussell, PhD",
        "Adam Galan, PhD",
        "Toni Kline, PhD",
        "Nicki Vasquez, PhD",
        "Alice Yam, PhD",
        "Ryan Stafford, PhD",
        "Henry Heinsohn",
        "Aaron Sato, PhD",
        "Arturo Molina, MD MS",
        "Trevor Hallam, PhD",
        "Mark Lupher, Jr., PhD"
    ],
    "author_dict_list": [
        {
            "author_name": "Cristina Abrahams, PhD",
            "author_affiliations": [
                "Sutro Biopharma, South San Francisco, CA "
            ],
            "author_rank": 1,
            "first_author": 1,
            "last_author": 0
        },
        {
            "author_name": "Xiaofan Li, PhD",
            "author_affiliations": [
                "Sutro Biopharma, South San Francisco, CA "
            ],
            "author_rank": 2,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Abigail Yu, PhD",
            "author_affiliations": [
                "Sutro Biopharma, South San Francisco, CA "
            ],
            "author_rank": 3,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Stellanie Krimm",
            "author_affiliations": [
                "Sutro Biopharma, South San Francisco, CA "
            ],
            "author_rank": 4,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Jason Kahana, PhD",
            "author_affiliations": [
                "Celgene, San Diego, CA"
            ],
            "author_rank": 5,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Rama Krishna Narla, PhD",
            "author_affiliations": [
                "Celgene, San Diego, CA"
            ],
            "author_rank": 6,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Eric Schwartz, PhD",
            "author_affiliations": [
                "Celgene, San Diego, CA"
            ],
            "author_rank": 7,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "John Boylan, PhD",
            "author_affiliations": [
                "Celgene, San Diego, CA"
            ],
            "author_rank": 8,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Heidi Hoffmann, PhD",
            "author_affiliations": [
                "Sutro Biopharma, South San Francisco, CA "
            ],
            "author_rank": 9,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Alexander Steiner, M.S.",
            "author_affiliations": [
                "Sutro Biopharma, South San Francisco, CA "
            ],
            "author_rank": 10,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "James Zawada, PhD",
            "author_affiliations": [
                "Sutro Biopharma, South San Francisco, CA "
            ],
            "author_rank": 11,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Heather Stephenson",
            "author_affiliations": [
                "Sutro Biopharma, South San Francisco, CA "
            ],
            "author_rank": 12,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Maureen Bruhns, PhD",
            "author_affiliations": [
                "Sutro Biopharma, South San Francisco, CA "
            ],
            "author_rank": 13,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Venita DeAlmeida, PhD",
            "author_affiliations": [
                "Sutro Biopharma, South San Francisco, CA "
            ],
            "author_rank": 14,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Shannon Matheny, PhD",
            "author_affiliations": [
                "Sutro Biopharma, South San Francisco, CA "
            ],
            "author_rank": 15,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Stuart Bussell, PhD",
            "author_affiliations": [
                "Sutro Biopharma, South San Francisco, CA "
            ],
            "author_rank": 16,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Adam Galan, PhD",
            "author_affiliations": [
                "Sutro Biopharma, South San Francisco, CA "
            ],
            "author_rank": 17,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Toni Kline, PhD",
            "author_affiliations": [
                "Sutro Biopharma, South San Francisco, CA "
            ],
            "author_rank": 18,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Nicki Vasquez, PhD",
            "author_affiliations": [
                "Sutro Biopharma, South San Francisco, CA "
            ],
            "author_rank": 19,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Alice Yam, PhD",
            "author_affiliations": [
                "Sutro Biopharma, South San Francisco, CA "
            ],
            "author_rank": 20,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Ryan Stafford, PhD",
            "author_affiliations": [
                "Sutro Biopharma, South San Francisco, CA "
            ],
            "author_rank": 21,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Henry Heinsohn",
            "author_affiliations": [
                "Sutro Biopharma, South San Francisco, CA "
            ],
            "author_rank": 22,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Aaron Sato, PhD",
            "author_affiliations": [
                "Sutro Biopharma, South San Francisco, CA "
            ],
            "author_rank": 23,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Arturo Molina, MD MS",
            "author_affiliations": [
                "Sutro Biopharma, South San Francisco, CA "
            ],
            "author_rank": 24,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Trevor Hallam, PhD",
            "author_affiliations": [
                "Sutro Biopharma, South San Francisco, CA "
            ],
            "author_rank": 25,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Mark Lupher, Jr., PhD",
            "author_affiliations": [
                "Sutro Biopharma, South San Francisco, CA "
            ],
            "author_rank": 26,
            "first_author": 0,
            "last_author": 1
        }
    ],
    "datetime_abstract_obtained": "2022-06-08T02:20:48",
    "is_scraped": "1"
}